Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Life-Space is a leading Australian biotechnology and wellness company specializing in the research and development of multi-strain probiotic formulations. The company operates the Life-Space Global Microbiome Center, a dedicated R&D hub focused on advancing the scientific understanding of the human microbiome across various life stages. Their product portfolio includes specialized supplements for infants, children, pregnant women, and seniors, as well as targeted solutions for immune and digestive health. In 2018, Life-Space was acquired by the Chinese dietary supplement giant By-Health for approximately $690 million AUD, significantly expanding its global distribution and research capabilities. The company is recognized for its commitment to evidence-based formulations and high-quality manufacturing standards in the microbiome space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Life-space Global Microbiome Center.